![](\"https:\/\/mms.businesswire.com\/media\/20260707790413\/en\/2846792\/5\/BioIVT_4C_Tag_ONLY-01.jpg\")
<\/a><\/a>\nAs precision oncology continues to evolve, translational research programs are increasingly looking beyond genomics-only approaches to better understand treatment response and disease progression. Noah\u2019s session will examine the limitations of genomics-only approaches and demonstrate how combining analyte classes such as cfRNA, proteins, extracellular vesicles, and spatial tumor biology can enhance our understanding of diseases.<\/p>
\n\u201cCancer therapies are becoming more advanced, so it\u2019s critical that researchers get a clearer picture of what\u2019s happening in the body,\u201d said Noah. \u201cDNA alone can\u2019t always explain why a patient responds in a certain way, or why resistance develops. Attendees will leave with a practical framework for using multi-omic approaches to strengthen biomarker research.\u201d<\/p>
\nIn addition to Noah\u2019s session, BioIVT will have a dedicated table at the event where attendees can stop by to learn how the company can help them obtain high-quality control and disease state biofluids, tissues, and other biospecimens.<\/p>
\nThroughout July, BioIVT will also attend several additional scientific and clinical research events, including:<\/p>
- \n
- \nInternational Society for Stem Cell Research (ISSCR)<\/a>, July 8-11 in Montreal, Canada, Booth 1002<\/li>\n
- \nAlzheimer\u2019s Association International Conference (AAIC)<\/a>, July 12-15 in London, England, Booth 1416<\/li>\n
- \nAssociation for Diagnostics & Laboratory Medicine (ADLM)<\/a>, July 26-30 in Anaheim, California, Booth 1621<\/li>\n<\/ul>
\nFor more information or to connect with BioIVT at an upcoming event, please visit the company\u2019s events page on its website<\/a>.<\/p>
\nAbout BioIVT<\/b><\/p>
\nBioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to the life science and diagnostic industries. We specialize in control and disease state samples including human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE\u00ae<\/sup>. For more information, please visit www.bioivt.com<\/a> or follow us on LinkedIn<\/a>.<\/p>
\nBioIVT Contact:<\/b> Charlie Chungu, Vice President of Marketing, cchungu@bioivt.com<\/a>
Dr. Courtney Noah to present on the evolution of oncology biomarker discovery and the role of integrated multi-omic workflows in translational researchWOODBURY, N.Y.–(BUSINESS WIRE)–BioIVT, a global research partner and biospecimen solutions provide…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32831","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32831","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=32831"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32831\/revisions"}],"predecessor-version":[{"id":32832,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/32831\/revisions\/32832"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=32831"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=32831"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=32831"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- \nAlzheimer\u2019s Association International Conference (AAIC)<\/a>, July 12-15 in London, England, Booth 1416<\/li>\n